Twenty years ago, WellSpan child psychiatrist Dr. Mike Fueyo had a dream: to create a one-stop center where families of ...
9d
How A New Genetic Test Is Transforming A Generation Of Moms—And Completely Remaking Family Planning
The Human Genome Project, launched in 1990 and completed in 2003, also moved the needle. Scientists had successfully ...
To mark Fragile X awareness day today and the 35th anniversary of the Fragile X Society, Queen’s University and the Fragile X ...
Servier is souping up its neurology pipeline with a clinical-stage candidate sourced from U.K. biotech Kaerus Bioscience for a rare genetic disease. The French pharma is offering as much as $450 ...
Les Laboratoires Servier said that it agreed to acquire a potential treatment for Fragile X syndrome (FXS), the most common genetic cause of autism spectrum disorder (ASD), from its original developer ...
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193, a novel, orally bioavailable small molecule, was granted Orphan ...
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ...
FORT WAYNE, Ind. (WANE) – Families can check out classic cars, trucks, and more this month—all while supporting a cause close to home. Organizers of Cruise-In for a Cause joined us on First News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback